AI assistant
Sending…
Oramed Pharmaceuticals Inc. — Director's Dealing 2012
Sep 27, 2012
6965_dirs_2012-09-27_97a3ac34-b567-47b8-b27d-4e705938cd16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ORAMED PHARMACEUTICALS INC. (ORMP.OB)
CIK: 0001176309
Period of Report: 2012-09-24
Reporting Person: OSTROV GERALD M (Director)
More from Oramed Pharmaceuticals Inc.
Interim / Quarterly Report
2026
May 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Capital/Financing Update
2026
Feb 20
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Jan 29
Major Shareholding Notification
2026
Jan 29
Director's Dealing
2026
Jan 29